SEMILLEROS TECNOLOGICOS

Menu
  • HOME
  • ILLNESSES AND CONDITIONS
  • SYMPTOMS AND SELF-HELP
  • LIVING HEALTHY
  • Interesting

Tennis Elbow (Lateral Epicondylitis: Symptoms and Causes)

What is the best treatment for tennis elbow?

Tennis elbow can be treated with a variety of medications, both over-the counter and prescription.

Over the counter medications

Ibuprofen and naproxen can reduce the inflammation and pain associated with tennis elbow. Ibuprofen, a common over the counter medication, can be used for tennis elbow. It reduces inflammation and pain. Naproxen can be used topically or orally as an anti-inflammatory. You should consult your doctor prior to taking naproxen as it may interact with other medications.

Prescription medication

Tennis elbow can be treated with a variety of prescription medications.

Corticosteroids

Tennis elbow can be treated with corticosteroids. These powerful anti-inflammatory medications can reduce swelling and discomfort. These are usually injected into the elbow and can be repeated as necessary.

Corticosteroids may help reduce inflammation and pain, as well as improve range of movement. They are not always effective and can cause side effects like pain at the injection sites, infection or nerve damage.

Platelet rich plasma injections

Injections of platelet-rich plasma can be used to treat pain and improve functionality. PRP is made of your own blood, and it helps to promote healing. These platelets contain growth factors that can promote healing and repair tissue. Injecting PRP into your elbow can reduce pain and improve functionality.

The injections of PRP are generally considered safe, and they have very few side effects. The most common adverse effect is temporary pain at the injection site. A small infection risk is present. The injections of PRP are usually done as an outpatient procedure, so you won’t need to spend the night in hospital.

Next Page
Share
Tweet
Email

Popular Posts

    SEMILLEROS TECNOLOGICOS

    Copyright © 2025 SEMILLEROS TECNOLOGICOS
    About Us | Contact Us | EU Policy | Privacy Policy | Terms of Use

    Ad Blocker Detected

    Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

    Refresh